Who Should Seriously Consider Bariatric Surgery — Especially in the Era of GLP-1s?
Ozempic, Wegovy and Mounjaro have changed the weight-loss conversation — but half of patients stop within a year, and most of the weight returns. Dr Cha explains who still benefits most from surgery, and why durability is its greatest advantage.
Read Article →